(Q41484952)

1 October 2017

1 reference

title

Hypokalemia and hyperkalemia (English)

1 reference

1 October 2017

Mandal AK

1

1 reference

1 October 2017

publication date

1 May 1997

1 reference

Medical Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

81

1 reference

1 October 2017

issue

3

1 reference

1 October 2017

page(s)

611-639

1 reference

Interactions between the renin-angiotensin system and prostanoids in modulating renal function in potassium-depleted healthy women

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Disturbances of Potassium Homeostasis in Poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Indapamide-induced severe hyponatremia and hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Acute renal failure following hypokalemic rhabdomyolysis due to chronic glycyrrhizic acid administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Relation of cardiovascular disease to potassium and magnesium deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Control of serum potassium during fasting in patients with end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Trimethoprim-sulfamethoxazole induces reversible hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Efficacy and safety of potassium infusion therapy in hypokalemic critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Which drugs affect potassium?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Drug-induced hypokalaemia. A cause for concern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Dietary potassium and stroke-associated mortality. A 12-year prospective population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Effect of cetamolol on epinephrine-induced hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Concentrated potassium chloride infusions in critically ill patients with hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Treatment of hyperkalaemia in renal failure: salbutamol v. insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Treatment of hyperkalaemia using intravenous and nebulised salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Heparin-induced aldosterone suppression and hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Renal failure and hyperkalemia associated with ketorolac tromethamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Excessive hypokalemia and hyperkalemia following head injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Glycyrrhizin (licorice)-induced hypokalemic myopathy. Report of 2 cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Antihypertensive action of heparin: role of the renin-angiotensin aldosterone system and prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Serum potassium concentrations in trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

Renal mechanism of trimethoprim-induced hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

The ability of physicians to predict hyperkalemia from the ECG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970536-8

10.1016/S0025-7125(05)70536-8

7 January 2021

Identifiers

DOI

1 reference

1 October 2017

1 reference